Epileptic activity originating from one or more diseased brain regions in the temporal lobe is difficult to contain. Many patients with so-called temporal lobe epilepsy often do not respond to ...

Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from ...

Please provide your email address to receive an email when new articles are posted on . Retrospective chart review included 29 patients with drug-resistant epilepsy who underwent LITT. Better 1-year ...

In a retrospective cohort, a clinical heuristic composed of eight binary variables helped identify which patients with medial temporal lobe epilepsy (MTLE) were best suited for stereotactic laser ...

Low dose resulted in 89% median disabling seizure reduction in participants with MTS during the 7-12-month primary efficacy ...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead ...

epileptic seizure Recurrence of seizures was reported in 28.2% of patients who attempted withdrawal. The majority of patients with mesial temporal lobe epilepsy who experience seizure recurrence ...

Please provide your email address to receive an email when new articles are posted on . Surgery for mesial temporal lobe epilepsy correlated with a reduction in imaging-defined brain age, indicating ...

A local woman who experienced regular epileptic seizures, and for years unsuccessfully sought a solution, is now seizure-free, thanks to a procedure conducted at Corewell Health William Beaumont ...